Key takeaway
In 101 hypertensive patients with moderate or severe periodontitis, intensive gum treatment lowered 24-hour systolic blood pressure by 11.1 mmHg more than basic treatment at 2 months (P < 0.001). The trial was small and short, so the size and durability of the effect still need confirming in a larger cohort.
Study design
Randomised trial
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
The research question
Inflammation is thought to drive high blood pressure, and periodontitis (a chronic gum infection) could feed that inflammation. Evidence in humans that gum disease actually raises blood pressure was scarce. The authors combined a genetic analysis with a randomized trial to test whether periodontitis and blood pressure are causally linked.
Who and how
Two parts. First, a two-sample Mendelian randomization analysis (using gene variants as natural experiments) in about 750 000 UK Biobank and International Consortium of Blood Pressure participants, using variants near SIGLEC5, DEFA1A3, MTND1P5 and LOC107984137 that are linked to periodontitis. Second, a randomized trial of 101 hypertensive patients with moderate or severe periodontitis: intensive periodontal treatment (sub- and supragingival scaling plus chlorhexidine; n = 50) versus control treatment (supragingival scaling only; n = 51). The primary outcome was mean 24-hour ambulatory systolic blood pressure. Periodontal status was assessed at 2 months. The abstract does not report blinding or the full follow-up schedule.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1In the genetic analysis, periodontitis-linked variants were significantly related to blood pressure measures. The abstract gives no effect sizes for this part.
- 2Intensive treatment improved gum health at 2 months compared with control treatment.
- 3Mean 24-hour systolic blood pressure fell 11.1 mmHg more with intensive than with control treatment (95% CI 6.5 to 15.8; P < 0.001). Larger improvements in gum health went with larger drops in systolic pressure.
- 4Diastolic blood pressure and endothelial function (flow-mediated dilatation, a measure of artery lining health) also improved with intensive treatment.
- 5Intensive treatment was accompanied by lower circulating IFN-γ and IL-6 and fewer activated (CD38+) and immunosenescent (CD57+CD28null) CD8+ T cells, immune markers previously linked to hypertension.
Limits & uncertainty
- 1Only 101 patients were randomized and the main comparison was at 2 months, so long-term effects on blood pressure and heart events are unknown.
- 2The authors describe the work as proof of concept for a larger trial, not as definitive evidence for treating gums to control hypertension.
- 3The genetic analysis rests on a few variants, and the abstract does not report its effect estimates, so its strength cannot be judged here.
- 4This reading is based on the abstract only.
What to take from it
Good gum care may matter for more than teeth, and this trial suggests periodontal treatment could help blood pressure in people who already have both conditions. It does not show that brushing or cleanings replace blood pressure medication. Anyone with hypertension or gum disease should discuss treatment with their doctor and dentist.
Reading your own data
If you track blood pressure with a home cuff, compare readings taken at the same time of day, seated and rested, and look at weekly averages rather than single readings. A change after dental treatment would show up only as a trend, and the 24-hour monitoring used in this trial is more thorough than occasional cuff checks.
How to read this evidence
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Aims
Inflammation is an important driver of hypertension. Periodontitis is a chronic inflammatory disease, which could provide a mechanism for pro-hypertensive immune activation, but evidence of a causal relationship in humans is scarce. We aimed to investigate the nature of the association between periodontitis and hypertension.
Methods and results
We performed a two-sample Mendelian randomization analysis in the ∼750 000 UK-Biobank/International Consortium of Blood Pressure-Genome-Wide Association Studies participants using single nucleotide polymorphisms (SNPs) in SIGLEC5, DEFA1A3, MTND1P5, and LOC107984137 loci GWAS-linked to periodontitis, to ascertain their effect on blood pressure (BP) estimates. This demonstrated a significant relationship between periodontitis-linked SNPs and BP phenotypes. We then performed a randomized intervention trial on the effects of treatment of periodontitis on BP. One hundred and one hypertensive patients with moderate/severe periodontitis were randomized to intensive periodontal treatment (IPT; sub- and supragingival scaling/chlorhexidine; n = 50) or control periodontal treatment (CPT; supragingival scaling; n = 51) with mean ambulatory 24-h (ABPM) systolic BP (SBP) as primary outcome. Intensive periodontal treatment improved periodontal status at 2 months, compared to CPT. This was accompanied by a substantial reduction in mean SBP in IPT compared to the CPT (mean difference of -11.1 mmHg; 95% CI 6.5-15.8; P < 0.001). Systolic BP reduction was correlated to periodontal status improvement. Diastolic BP and endothelial function (flow-mediated dilatation) were also improved by IPT. These cardiovascular changes were accompanied by reductions in circulating IFN-γ and IL-6 as well as activated (CD38+) and immunosenescent (CD57+CD28null) CD8+T cells, previously implicated in hypertension.
Conclusion
A causal relationship between periodontitis and BP was observed providing proof of concept for development of clinical trial in a large cohort of hypertensive patients. ClinicalTrials.gov: NCT02131922.
Sources & attribution
Causal association between periodontitis and hypertension: evidence from Mendelian randomization and a randomized controlled trial of non-surgical periodontal therapy.
Czesnikiewicz-Guzik M, Osmenda G, Siedlinski M, Nosalski R, Pelka P, Nowakowski D, Wilk G, Mikolajczyk TP, Schramm-Luc A, Furtak A, Matusik P, Koziol J, Drozdz M, Munoz-Aguilera E, Tomaszewski M, Evangelou E, Caulfield M, Grodzicki T, D'Aiuto F, Guzik TJ.
European heart journal · 2019-11-01
DOI: 10.1093/eurheartj/ehz646 ↗PubMed · 31504461 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people
Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.
Journal of the American Heart Association
Five exercise types lowered resting blood pressure, isometric training the most
Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.
British Journal of Sports Medicine
A salt substitute lowered stroke, major cardiovascular events and death in rural China
In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.
The New England Journal of Medicine
Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation
Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.
The New England Journal of Medicine

